Medline Inc. Class A (MDLN)

MDLN · Health Care · United States

Medline Inc. Class A (MDLN) is a company in the Health Care sector, based in United States. The stock is held in 16 ETFs we track – with its largest weight of 0.20 % in XUHL (msci-usa-health-care). Anyone holding one of these ETFs also owns a small indirect stake in Medline.

Above-average ETF coverage: 16 of the 95 ETFs we cover hold Medline, spread across 7 indices. That puts the stock in more ETFs than 76.4 % of the 4,334 stocks we cover.

Held in16 ETFs

Highest weight0.20 %

Indices7

SectorHealth Care

CountryUnited States

ISINUS58507V1070

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date	-21.5 %	1 year	–
1 month	-5.4 %	3 months	-9.4 %

52W

Data note 3

Measured in euros, Medline returned -20.0 % year to date. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 4

Risk metrics

Max drawdown-35.8 %

Volatility p.a.45.7 %

Data note 5

Below peak-34.0 %

The close on Sep 16, 2026 was 34.0 % below the highest close since Dec 17, 2025, reached on Feb 24, 2026.

Data note 6

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
Insulet Corporation	+0.50
DaVita Inc.	+0.49
Baxter International Inc.	+0.46
Kraft Heinz Company	+0.45
Flutter Entertainment plc	+0.44
Lowe's Companies Inc.	+0.44
Brent crude oil	-0.35
WTI crude oil	-0.34
Targa Resources Corp.	-0.31

Data note 7

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.

Revenue28.4 bn $

Net income1157.0 bn $

Diluted EPS-0.01 $

Net margin4069.4 %

Gross margin26.4 %

Return on equity10775.8 %

Equity ratio27.9 %

Revenue growth+11.5 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	23.2	–	–
FY2024	25.5	–	–
FY2025	28.4	1157.0	4069.4 %

Data note 8

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XUHL / XUHC	msci-usa-health-care	0.20 %	€2.00
XDWH	msci-world-health-care	0.15 %	€1.50
SPFS	msci-world-health-care	0.15 %	€1.50
SWWD	msci-world	0.02 %	€0.20
SPPW	msci-world	0.02 %	€0.20
XD9U / XD9D	msci-usa	0.02 %	€0.20
WIMI	msci-world-imi	0.01 %	€0.10
SPYY	msci-acwi	0.01 %	€0.10
EUNL	msci-world	0.01 %	€0.10
IUSQ	msci-acwi	0.01 %	€0.10
XDWD / XDWL	msci-world	0.01 %	€0.10
SPYI / SPSA	msci-acwi-imi	0.00 %	€0.00

Data note 9

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Medline as of the fund's latest holdings list.

How much Medline Inc. Class A overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Medline — the figure counts the ETFs holding both.

Data note 10

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
Medline	–	45.7 %	4069.4 %	+11.5 %
Insmed Incorporated	-15.3 %	54.9 %	-210.5 %	+66.7 %
Natera	+97.3 %	47.0 %	-9.0 %	+35.9 %
Neurocrine Biosciences	+6.1 %	36.8 %	16.7 %	+21.4 %
Illumina	+125.6 %	45.3 %	19.6 %	-0.7 %
Roivant Sciences	+179.1 %	39.6 %	-3629.2 %	-71.6 %
Revolution Medicines	+338.3 %	56.9 %	–	–
Boston Scientific Corporation	-55.6 %	31.0 %	–	+19.9 %
Danaher Corporation	+9.4 %	30.6 %	14.7 %	+2.9 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.